Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea · Delayed Price · Currency is KRW

8,430.00

-50.00 (-0.59%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medicines			349.71B	286.81B	282.30B	290.18B	272.96B
Medicines Growth			21.93%	1.60%	-2.71%	6.31%	14.23%
Food			567.36B	563.72B	542.93B	474.14B	475.93B
Food Growth			0.65%	3.83%	14.51%	-0.38%	3.89%
MRO			605.38B	589.81B	523.26B	492.67B	500.86B
MRO Growth			2.64%	12.72%	6.21%	-1.63%	0.67%
Other			17.49B	19.88B	13.43B	15.39B	15.77B
Other Growth			-12.00%	48.00%	-12.76%	-2.38%	-8.57%
Consolidation Adjustment			-25.48B	-28.67B	-23.74B	-28.61B	-27.26B
Total			1.51T	1.43T	1.34T	1.24T	1.24T
Total Growth			5.79%	6.98%	7.59%	0.45%	4.92%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Korea			1.51T	1.42T	1.33T	1.24T	1.23T
Korea Growth			6.13%	7.14%	7.37%	0.85%	4.53%
Asia			29.26B	37.99B	34.46B	36.00B	39.62B
Asia Growth			-22.98%	10.26%	-4.29%	-9.12%	1.31%
Europe			1.22B	-	-	-	-
Consolidation Adjustment			-25.48B	-28.67B	-23.74B	-28.61B	-27.26B
Total			1.51T	1.43T	1.34T	1.24T	1.24T
Total Growth			5.79%	6.98%	7.59%	0.45%	4.92%

Source: S&P Global Market Intelligence.